An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 5 - 21 |
| Updated: | 7/4/2018 |
| Start Date: | February 1, 2015 |
| End Date: | January 1, 2017 |
The purpose of this study is to try to treat bowel movement (BM) accidents differently with
children with autism spectrum disorder (ASD). The study will use over-the-counter (OTC)
medications to evoke predictable bowel movements. This will make it possible for
investigators to use certain strategies to reward BMs in the toilet. Independence will be
increased by fading out the use of medications. The investigators will also train caregivers
to implement the procedures.
children with autism spectrum disorder (ASD). The study will use over-the-counter (OTC)
medications to evoke predictable bowel movements. This will make it possible for
investigators to use certain strategies to reward BMs in the toilet. Independence will be
increased by fading out the use of medications. The investigators will also train caregivers
to implement the procedures.
A large percentage of individuals with autism spectrum disorder (ASD) are delayed in
achieving continence with bowel movements or never achieve it at all (i.e., they meet
criteria for encopresis). This problem has tremendous ramifications for these individuals and
their families because encopresis restricts them from integration with peers, limits access
to educational opportunities, and carries significant social stigma. Previous interventions
for encopresis in this population have either been unsuccessful or required implementation
over very long periods.
achieving continence with bowel movements or never achieve it at all (i.e., they meet
criteria for encopresis). This problem has tremendous ramifications for these individuals and
their families because encopresis restricts them from integration with peers, limits access
to educational opportunities, and carries significant social stigma. Previous interventions
for encopresis in this population have either been unsuccessful or required implementation
over very long periods.
Inclusion Criteria:
- Age 5-21
- Confirmed diagnosis of autistic spectrum disorder using the Social Communication
Questionnaire (SCQ) and the Childhood Autism Rating Scale II (CARSII)
- Clearance from gastroenterologist for use of glycerin suppository, bisacodyl
suppository and senna
- Caregiver willing to give consent/assent
Exclusion Criteria:
- Age under 5 year or over 21 years
- Does not present a diagnosis of autistic spectrum disorder
- Previous intestinal surgeries or concurrent enuresis
- Caregiver unwilling to give consent/assent
We found this trial at
1
site
Atlanta, Georgia 30329
Principal Investigator: Nathan Call, PhD
Phone: 404-785-9618
Click here to add this to my saved trials
